Jennifer Doudna (UC Berkeley) (Jun 2017)
CRISPR-Cas systems are adaptive immune responses in bacteria that protect against viruses by cleaving foreign DNA. CRISPR-Cas9 technology allows for precise genome editing in eukaryotic cells, raising ethical considerations and the need for responsible progress.









